Spinal muscular atrophy: Molecular pathophysiology

Current Opinion in Neurology

Volumn 12, Issue 2, 1999, Pages 137-142

  Gendron, Nathalie H ^a   MacKenzie, Alex E ^a,b  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INHIBITOR PROTEIN;

CELL SURVIVAL; CELL TYPE; CLINICAL FEATURE; EMBRYONAL TISSUE; EXON; GENE ACTIVATION; GENE DELETION; GENE EXPRESSION; GENE MAPPING; GENE THERAPY; HUMAN; LETHAL GENE; MOTOR NEURON DISEASE; MUSCLE ATROPHY; MUSCLE WEAKNESS; NONHUMAN; PEDIATRICS; PROTEIN MODIFICATION; REVIEW; SEQUENCE ANALYSIS; SPINAL MUSCULAR ATROPHY; SPLICEOSOME; TARGET ORGAN;

AUTOANTIGENS; CELL SURVIVAL; CHILD; GENE THERAPY; HUMANS; MOTOR NEURONS; MUSCULAR ATROPHY, SPINAL; NERVE TISSUE PROTEINS; NEURONAL APOPTOSIS-INHIBITORY PROTEIN; PROTEIN ISOFORMS; RIBONUCLEOPROTEINS, SMALL NUCLEAR; SEVERITY OF ILLNESS INDEX;

EID: 0032953864     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199904000-00002     Document Type: Review

References (70)

1. Dubowitz V. Muscle disorders in childhood, 2nd ed. London, Philadelphia: Saunders; 1995.
2. Brzustowicz LM, Lehner T, Castilla LH, Penchaszadeh GK, Wilhelmsen KC, Daniels R, et al. Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3. Nature 1990; 344:540-541.
3. Gilliam TC, Brzustowicz LM, Castilla LH, Lehner T, Penchaszadeh GK, Daniels RJ, et al. Genetic homogeneity between acute and chronic forms of spinal muscular atrophy. Nature 1990; 345:823-825.
4. Melki J, Sheth P, Abdelhak S, Burlet P, Bachelot MF, Lathrop MG, et al. Mapping of acute (type I) spinal muscular atrophy to chromosome 5q12-q14. The French Spinal Muscular Atrophy Investigators. Lancet 1990; 336:271-273.
5. Melki J, Abdelhak S, Sheth P, Bachelot MF, Burlet P, Marcadet A, et al. Gene for chronic proximal spinal muscular atrophies maps to chromosome 5q. Nature 1990; 344:767-768.
6. Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995; 80:155-165.
7. Roy N, Mahadevan MS, McLean M, Shutler G, Yaraghi Z, Farahani R, et al. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 1995; 80:167-178.
8. Scharf JM, Endrizzi MG, Wetter A, Huang S, Thompson TG, Zerres K, et al. Identification of a candidate modifying gene for spinal muscular atrophy by comparative genomics. Nature Genet 1998; 20:83-86.
9. Burglen L, Seroz T, Miniou P, Lefebvre S, Burlet P, Munnich A, et al. The gene encoding p44, a subunit of the transcription factor TFIIH, is involved in large-scale deletions associated with Werdnig-Hoffmann disease. Am J Hum Genet 1997; 60:72-79.
10. Carter TA, Bonnemann CG, Wang CH, Obici S, Parano E, De Fatima Bonaldo M, et al. A multicopy transcription-repair gene, BTF2p44, maps to the SMA region and demonstrates SMA associated deletions. Hum Mol Genet 1997; 6:229-336.
11. Burglen L, Lefebvre S, Clermont O, Burlet P, Viollet L, Cruaud C, et al. Structure and organization of the human survival motor neurone (SMN) gene. Genomics 1996; 32:479-482.
12. Bussaglia E, Clermont O, Tizzano E, Lefebvre S, Burglen L, Cruaud C, et al. A frame-shift deletion in the survival motor neuron gene in Spanish spinal muscular atrophy patients. Nature Genet 1995; 11:335-337.
13. Chang JG, Jong YJ, Huang JM, Wang WS, Yang TY, Chang CP, et al. Molecular basis of spinal muscular atrophy in Chinese. Am J Hum Genet 1995; 57:1503-1505.
14. Cobben JM, van der Steege G, Grootscholten P, de Visser M, Scheffer H, Buys CH. Deletions of the survival motor neuron gene in unaffected siblings of patients with spinal muscular atrophy. Am J Hum Genet 1995; 57:805-808.
15. Hahnen E, Forkert R, Marke C, Rudnik-Schoneborn S, Schonling J, Zerres K, et al. Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: evidence of homozygous deletions of the SMN gene in unaffected individuals. Hum Mol Genet 1995; 4:1927-1933
16. Rodrigues NR, Owen N, Talbot K, Ignatius J, Dubowitz V, Davies KE. Deletions in the survival motor neuron gene on 5q13 in autosomal recessive spinal muscular atrophy. Hum Mol Genet 1995; 4:631-634.
17. van der Steege G, Grootscholten PM, van der Vlies P, Draaijers TG, Osinga J, Cobben JM, et al. PCR-based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy. Lancet 1995; 345:985-986.
18. Brahe C, Clermont O, Zappata S, Tiziano F, Melki J, Neri G. Frameshift mutation in the survival motor neuron gene in a severe case of SMA type I. Hum Mol Genet 1996; 5:1971-1976.
19. Parsons DW, McAndrew PE, Monani UR, Mendell JR, Burghes AH, Prior TW. An 11 base pair duplication in exon 6 of the SMN gene produces a type I spinal muscular atrophy (SMA) phenotype: further evidence for SMN as the primary SMA-determining gene. Hum Mol Genet 1996; 5:1727-1732.
20. Velasco E, Valero C, Valero A, Moreno F, Hernandez-Chico C. Molecular analysis of the SMN and NAIP genes in Spanish spinal muscular atrophy (SMA) families and correlation between number of copies of cBCD541 and SMA phenotype. Hum Mol Genet 1996; 5:257-263.
21. Hahnen E, Schonling J, Rudnik-Schoneborn S, Raschke H, Zerres K, Wirth B. Missense mutations in exon 6 of the survival motor neuron gene in patients with spinal muscular atrophy (SMA). Hum Mol Genet 1997; 6:821-825.
22. Wirth B, Schmidt T, Hahnen E, Rudnik-Schoneborn S, Krawczak M, Muller-Myhsok B, et al. De novo rearrangements found in 2% of index patients with spinal muscular atrophy: mutational mechanisms, parental origin, mutation rate, and implications for genetic counseling. Am J Hum Genet 1997; 61:1102-1111.
23. Coovert DD, Le TT, McAndrew PE, Strasswimmer J, Crawford TO, Mendell JR, et al. The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet 1997; 6:1205-1214. See [24•].
24. Lefebvre S, Burlet P, Liu Q, Bertrandy S, Clermont O, Munnich A, et al. Correlation between severity and SMN protein level in spinal muscularatrophy. Nature Genet 1997; 16:265-269. This paper and [23*] provide important delineation of the inverse correlation between protein concentration and clinical severity. The role of SMN as the primary cause of SMA had generally been appreciated before this stage as a result of genetic analyses; these reports showed that SMN was also likely largely responsible for the range of clinical severity.
25. Liu Q, Dreyfuss G. A novel nuclear structure containing the survival of motor neurons protein. Embo J 1996; 15:3555-3565.
26. Liu Q, Fischer U, Wang F, Dreyfuss G. The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell 1997; 90:1013-1021. See [27••].
27. Fischer U, Liu Q, Dreyfuss G. The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis. Cell 1997; 90:1023-1029. This paper and [26••,28••] have revealed the essential role of SMN in spliceosomal biogenesis - impressive cellular and molecular biochemistry in its own right but which is also critical to our understanding of what is likely the precise cellular function gone awry in SMA.
28. Pellizzoni L, Kataoka N, Charroux B, Dreyfuss G. A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing. Cell 1998; 95:615-624. See [27••].
29. Lorson CL, Androphy EJ. The domain encoded by exon 2 of the survival motor neuron protein mediates nucleic acid binding. Hum Mol Genet 1998;7:1269-1275. See [31•].
30. Bertrandy S, Clermont O, Burlet P, Cruaud C, Huber C, Fondrat C, et al. Recombinant SMN protein from the zebrafish ortholog of the SMA-causing gene exhibits RNA-binding properly. In: The American Society of Human Genetics 48th annual meeting. Byers PH (editor). Denver, CO: Chicago University Press; 1998. p. A263.
31. Lorson CL, Strasswimmer J, Yao JM, Baleja JD, Hahnen E, Wirth B, et al. SMN oligomerization defect correlates with spinal muscular atrophy severity. Nature Genet 1998; 19:63-66. With regard to this paper and [29•], clearly there are pieces of the SMN puzzle that remain, RNA binding and possibly self-association being two of them.
32. Sato S, Burgess S, McIlwain D. Transcription and motoneuron size. J Neurochem 1994; 63:1609-1615.
33. Schrank B, Gotz R, Gunnersen JM, Ure JM, Toyka KV, Smith AG, et al. Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc Natl Acad Sci U S A 1997; 94:9920-9925.
34. Scharf JM, Damron D, Frisella A, Bruno S, Beggs AH, Kunkel LM, et al. The mouse region syntenic for human spinal muscular atrophy lies within the Lgn1 critical interval and contains multiple copies of Naip exon 5. Genomics 1996; 38:405-417.
35. Bergin A, Kim G, Price DL, Sisodia SS, Lee MK, Rabin BA. Identification and characterization of a mouse homologue of the spinal muscular atrophy-determining gene, survival motor neuron. Gene 1997; 204:47-53.
36. DiDonato CJ, Chen XN, Noya D, Korenberg JR, Nadeau JH, Simard LR. Cloning, characterization, and copy number of the murine survival motor neuron gene: homolog of the spinal muscular atrophy-determining gene. Genome Res 1997; 7:339-352.
37. Battaglia G, Princivalle A, Forti F, Lizier C, Zeviani M. Expression of the SMN gene, the spinal muscular atrophy determining gene, in the mammalian central nervous system. Hum Mol Genet 1997; 6:1961-1971.
38. Burlet L, Hubert C, Bertrandy S, Ludosky MA, Zwaenepoel L, Clermont O, et al. The distribution of SMN protein complex in human fetal tissues and its alteration in spinal muscular atrophy. Hum Mol Genet 1998; 7:1927-1933.
39. Tizzano EF, Cabot C, Baiget M. Cell-specific survival motor neuron gene expression during human development of the central nervous system: implications for the pathogenesis of spinal muscular atrophy. Am J Pathol 1998; 153:355-361.
40. La Bella V, Cisterni C, Salaun D, Pettmann B. Survival motor neuron (SMN) protein in rat is expressed as different molecular forms and is developmentally regulated. Eur J Neurosci 1998;10:2913-2923.
41. Chou SM, Fakadej AV. Ultrastructure of chromatolytic motorneurons and anterior spinal roots in a case of Werdnig-Hoffmann disease. J Neuropathol Exp Neurol 1971; 30:368-379.
42. Murayama S, Bouldin TW, Suzuki K. Immunocytochemical and ultrastructural studies of Werdnig-Hoffmann disease. Acta Neuropathol 1991; 81:408-417.
43. Devriendt K, Lammens M, Schollen E, Van Hole C, Dom R, Devlieger H, et al. Clinical and molecular genetic features of congenital spinal muscular atrophy. Ann Neurol 1996; 40:731-738.
44. Fidzianska A, Goebel HH, Warlo I. Acute infantile spinal muscular atrophy. Muscle apoptosis as a proposed pathogenetic mechanism. Brain 1990; 113:433-445.
45. Braun S, Croizat B, Lagrange MC, Warter JM, Poindron P. Constitutive muscular abnormalities in culture in spinal muscular atrophy. Lancet 1995; 345:694-695.
46. Guettier-Sigrist S, Coupin G, Braun S, Warter JM, Poindron P. Muscle could be the therapeutic target in SMA treatment. J Neurosci Res 1998;53:663-669. Despite the general perception that the motor neurone is the primary and perhaps exclusive site of pathology in SMA, the carefully conducted studies described in this paper and [45] make a strong argument for a significant primary muscle involvement.
47. Iwahashi H, Eguchi Y, Yasuhara N, Hanafusa T, Matsuzawa Y, Tsujimoto Y. Synergistic anti-apoptotic activity between Bcl-2 and SMN implicated in spinal muscular atrophy. Nature 1997; 390:413-417.
48. Morrison KE. Advances in SMA research: review of gene deletions. Neuromusc Disord 1996; 6:397-408.
49. Crawford TO, Pardo CA. The neurobiology of childhood spinal muscular atrophy. Neurobiol Dis 1996; 3:97-110.
50. Wang CH, Carter TA, Das K, Xu J, Ross BM, Penchaszadeh GK, et al. Extensive DNA deletion associated with severe disease alleles on spinal muscular atrophy homologues. Ann Neurol 1997; 42:41-49.
51. Schwartz M, Sorensen N, Hansen FJ, Hertz JM, Norby S, Tranebjaerg L, et al. Quantification, by solid-phase minisequencing, of the telomeric and centromeric copies of the survival motor neuron gene in families with spinal muscular atrophy. Hum Mol Genet 1997; 6:99-104.
52. Monani U, Kathuria S, Offenbaker J, Burghes A, McPherson J. Sequence differences and promoter analysis of the survival motor neuron (SMNc and SMNt) genes. In: The American Society of Human Genetics 47th annual meeting. Byers PH (editor). Baltimore, MA: University of Chicago Press; 1997.
53. Matthijs G, Schollen E, Legius E, Devriendt K, Goemans N, Kayserili H, et al. Unusual molecular findings in autosomal recessive spinal muscular atrophy. J Med Genet 1996; 33:469-474.
54. McAndrew PE, Parsons DW, Simard LR, Rochette C, Ray PN, Mendell JR, et al. Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet 1997; 60:1411-1422.
55. Gennarelli M, Lucarelli M, Capon F, Pizzuti A, Merlini L, Angelini C, et al. Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients. Biochem Biophys Res Commun 1995; 213:342-348.
56. Hahnen E, Schonling J, Rudnik-Schoneborn S, Zerres K, Wirth B. Hybrid survival motor neuron genes in patients with autosomal recessive spinal muscular atrophy: new insights into molecular mechanisms responsible for the disease. Am J Hum Genet 1996; 59:1057-1065.
57. van der Steege G, Grootscholten PM, Cobben JM, Zappata S, Scheffer H, den Dunnen JT, et al. Apparent gene conversions involving the SMN gene in the region of the spinal muscular atrophy locus on chromosome 5. Am J Hum Genet 1996; 59:834-838.
58. Burghes AH. When is a deletion not a deletion? When it is converted. Am J Hum Genet 1997; 61:9-15.
59. Campbell L, Potter A, Ignatius J, Dubowitz V, Davies K. Genomic variation and gene conversion in spinal muscular atrophy: implications for disease process and clinical phenotype. Am J Hum Genet 1997; 61:40-50.
60. DiDonato CJ, Ingraham SE, Mendell JR, Prior TW, Lenard S, Moxley RT III, et al. Deletion and conversion in spinal muscular atrophy patients: is there a relationship to severity? Ann Neurol 1997; 41:230-237.
61. Taylor JE, Thomas NH, Lewis CM, Abbs SJ, Rodrigues NR, Davies KE, et al. Correlation of SMNt and SMNc gene copy number with age of onset and survival in spinal muscular atrophy. Eur J Hum Genet 1998; 6:467-474.
62. Chen Q, Baird SD, Mahadevan M, Besner-Johnston A, Farahani R, Xuan J, et al. Sequence of a 131-kb region of 5q13.1 containing the spinal muscular atrophy candidate genes SMN and NAIP. Genomics 1998; 48:121-127.
63. Samilchuk E, D'Souza B, Bastaki L, al-Awadi S. Deletion analysis of the SMN and NAIP genes in Kuwaiti patients with spinal muscular atrophy. Hum Genet 1996; 98:524-527.
64. Liston P, Roy N, Tamai K, Lefebvre C, Baird S, Cherton-Horvat G, et al. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 1996; 379:349-353.
65. Xu DG, Crocker SJ, Doucet JP, St-Jean M, Tamai K, Hakim AM, et al. Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus. Nature Med 1997; 3:997-1004. This paper and [64] provide documentation of the in-vitro and in-vivo apoptotic inhibitory capability of NAIP, and a suggestion of possible clinical effect with NAIP overexpression.
66. Kuida K, Zheng TS, Na S, Kuan C, Yang D, Karasuyama H, et al. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 1996; 384:368-372.
67. Li L, Prevette D, Oppenheim RW, Milligan CE. Involvement of specific caspases in motoneuron cell death in vivo and in vitro following trophic factor deprivation. Mol Cell Neurosci 1998; 12:157-167.
68. Xu DG, Korneluk RG, Tamai K, Wigle N, Hakim A, MacKenzie A, et al. Distribution of neuronal apoptosis inhibitory protein-like immunoreactivity in the rat central nervous system. J Comp Neurol 1997; 382:247-259.
69. MacKenzie AE. Reply to Burghes. Am J Hum Genet 1998;62:485-488.
70. Talbot K, Miguel-Aliaga I, Mohaghegh P, Ponting CP, Davies KE. Characterization of a gene encoding survival motor neurons (SMN)-related protein, a constituent of the spliceosome complex. Hum Mol Genet 1998; 7:2149-2156.